EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

ESR1-Guided Endocrine Switching in HR-Positive Metastatic Breast Cancer: From Detection to Risk-Adapted Decision in SERENA-6

Atlal Abusanad iD

Journal of Immunotherapy and Precision Oncology · 23.07.2026 · 9 (3) · 120-123

DOI: 10.36401/jipo-26-5 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Immunotherapy and Precision Oncology, erschienen am 23.07.2026. Verfasst von Atlal Abusanad. Beteiligte Einrichtung: Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia. Die Arbeit nennt 13 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

ESR1 mutationSERDaromatase inhibitorbreast cancerctDNAhormone receptorprecision oncologyselective estrogen receptor degrader

Autor:innen und Institutionen

  • Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia.
  • Medical Oncology Division, Department of medicine, King Abdulaziz University Hospital, Jeddah, Saudi Arabia.

ORCID-Profile: Atlal Abusanad

Zitieren

APA

Abusanad, A. (2026). ESR1-Guided Endocrine Switching in HR-Positive Metastatic Breast Cancer: From Detection to Risk-Adapted Decision in SERENA-6. Journal of Immunotherapy and Precision Oncology, 9(3), 120-123. https://doi.org/10.36401/jipo-26-5

Vancouver

Abusanad A. ESR1-Guided Endocrine Switching in HR-Positive Metastatic Breast Cancer: From Detection to Risk-Adapted Decision in SERENA-6. Journal of Immunotherapy and Precision Oncology. 2026;9(3):120-123. doi:10.36401/jipo-26-5

BibTeX
@article{Abusanad2026,
  author = {Abusanad, Atlal},
  title = {ESR1-Guided Endocrine Switching in HR-Positive Metastatic Breast Cancer: From Detection to Risk-Adapted Decision in SERENA-6},
  journal = {Journal of Immunotherapy and Precision Oncology},
  year = {2026},
  volume = {9},
  number = {3},
  pages = {120--123},
  doi = {10.36401/jipo-26-5}
}
Kostenlos starten →